Each filer's latest filing for 78667J108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 7.2% |
4/17/2025
Event 3/31/2025
|
||
| Vanguard Group Inc 13G/A | 5.2% |
7/29/2025
Event 6/30/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
RTW Investments, LP
13G/A
|
4.9% |
2/14/2025
Event 12/31/2024
|
||
| RTW Investments, LP | 4.9% | |||
| Roderick Wong, M.D. | 4.9% | |||
|
BB Biotech AG
13G/A
|
1.9% |
1/17/2025
Event 1/13/2025
|
||
| BB Biotech AG | 1.9% | |||
| Biotech Target N.V. | 1.9% | |||
|
Morgan Stanley
13G/A
|
1.6% |
3/6/2025
Event 2/28/2025
|
||
| Morgan Stanley | 1.6% | |||
| Morgan Stanley & Co. LLC | 0.3% | |||
|
FMR LLC
13G/A
|
0.8% |
3/7/2025
Event 2/28/2025
|
||
| FMR LLC | 0.8% | |||
| Abigail P. Johnson | 0.8% | |||
|
Biogen Inc.
13D/A
|
0% |
7/30/2025
Event 7/30/2025
|
||
| Biogen Inc. | 0% | |||
| Biogen MA Inc. | 0% | |||
|
Madison Avenue Partners, LP
13G/A
|
0% |
11/14/2025
Event 9/30/2025
|
||
| Madison Avenue Partners, LP | 0% | |||
| Madison Avenue International LP | 0% | |||
| EMAI Management, LLC | 0% | |||
| Madison Avenue GP, LLC | 0% | |||
| Caraway Jackson Investments LLC | 0% | |||
| Eli Samaha | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 1.00 | $9 |
| 2026 Q1 | 1 | 1.00 | $9 |
| 2025 Q4 | 2 | 22.2 k | $460k |
| 2025 Q3 | 5 | 56.4 k | $494k |
| 2025 Q2 | 196 | 48.9 M | $446M |
| 2025 Q1 | 201 | 51.8 M | $411M |
| 2024 Q4 | 180 | 51.2 M | $278M |
| 2024 Q3 | 178 | 51.4 M | $374M |
| 2024 Q2 | 197 | 53.5 M | $581M |
| 2024 Q1 | 207 | 58.5 M | $1.10B |
| 2023 Q4 | 204 | 56.1 M | $1.22B |
| 2023 Q3 | 198 | 58.8 M | $1.21B |
| 2023 Q2 | 229 | 54.1 M | $2.54B |
| 2023 Q1 | 219 | 53.0 M | $2.22B |
| 2022 Q4 | 213 | 51.6 M | $2.44B |
| 2022 Q3 | 206 | 51.5 M | $2.02B |
| 2022 Q2 | 217 | 51.1 M | $1.65B |
| 2022 Q1 | 217 | 49.9 M | $1.65B |
| 2021 Q4 | 222 | 50.2 M | $2.14B |
| 2021 Q3 | 232 | 49.1 M | $2.17B |
| 2021 Q2 | 265 | 50.7 M | $2.88B |
| 2021 Q1 | 268 | 53.1 M | $3.97B |
| 2020 Q4 | 252 | 53.8 M | $4.65B |
| 2020 Q3 | 236 | 53.7 M | $3.28B |
| 2020 Q2 | 224 | 54.0 M | $2.25B |
| 2020 Q1 | 236 | 55.2 M | $1.59B |
| 2019 Q4 | 276 | 56.0 M | $4.04B |
| 2019 Q3 | 290 | 58.3 M | $8.18B |
| 2019 Q2 | 279 | 58.1 M | $10.6B |
| 2019 Q1 | 277 | 56.3 M | $8.95B |
| 2018 Q4 | 256 | 49.8 M | $4.76B |
| 2018 Q3 | 280 | 49.2 M | $6.95B |
| 2018 Q2 | 273 | 48.8 M | $7.64B |
| 2018 Q1 | 254 | 47.6 M | $7.65B |
| 2017 Q4 | 230 | 44.1 M | $7.26B |
| 2017 Q3 | 185 | 39.4 M | $2.46B |
| 2017 Q2 | 197 | 38.4 M | $3.06B |
| 2017 Q1 | 200 | 37.9 M | $2.69B |
| 2016 Q4 | 168 | 36.7 M | $1.88B |
| 2016 Q3 | 156 | 37.8 M | $1.74B |
| 2016 Q2 | 152 | 30.2 M | $918M |
| 2016 Q1 | 144 | 29.1 M | $932M |
| 2015 Q4 | 139 | 23.5 M | $1.37B |
| 2015 Q3 | 135 | 27.3 M | $1.17B |
| 2015 Q2 | 125 | 26.4 M | $1.93B |
| 2015 Q1 | 93 | 21.5 M | $1.08B |
| 2014 Q4 | 74 | 20.3 M | $736M |
| 2014 Q3 | 52 | 18.9 M | $596M |